CRNX — Crinetics Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $9.00bn
- $7.80bn
- $7.70m
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Crinetics will get more time after FDA setback for Camurus' rival drug, Piper Sandler says
Crinetics Pharmaceuticals Q1 revenue jumps on Palsonify launch
Brief: Crinetics Pharmaceuticals Q1 Net Income USD -127.845 Million
Crinetics Pharmaceuticals Q4 revenue rises
Brief: Crinetics Pharmaceuticals Q4 Net Income USD -122.815 Million
Brief: Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant In Congenital Adrenal Hyperplasia (Cah)
U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's
U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods
U.S. STOCKS ON THE MOVE-Colgate, Strategy, AAR Corp
Crinetics Pharma climbs after $350 mln stock sale
Brief: Crinetics Pharmaceuticals Prices Public Offering Of 7.6 Million Shares At $45.95 Each
U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla
U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin
U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge
U.S. STOCKS ON THE MOVE-Intel, Vistra, Jackson Financial
Crinetics Pharma ticks down after announcing $350 mln stock offering